When it comes to diseases like dementia, Parkinson’s, and ALS, Duke University cell biologist Chantell Evans thinks it’s time to look specifically at neurons. By unraveling how neurons deal with malfunctioning mitochondria, her work could open up possibilities for treating many currently incurable conditions.

Two researchers from Duke University School of Medicine and one from Duke’s Department of Biology have been named recipients of the 2022 Science Diversity Leadership Awards from the Chan Zuckerberg

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine 50 mg twice daily for 10 days for the treatment of mild-to-moderate COVID-19 symptoms.

It’s all too common for cancer patients to hear their doctors tell them they are no longer responding to their current treatment.

For decades, medical cancer treatment has generally meant chemotherapy, radiation, or surgery, alone or in combination. Today, new approaches such as immunotherapies and targeted therapies are becoming available, with many more in research and development.

Nicole Calakos, MD, PhD, a professor of neurology and Lincoln Financial Group Distinguished Professor of Neurobiology, has been elected to the U.S. National Academy of Medicine (NAM).  

L. Ebony Boulware, MD, MPH, Director of the Duke Clinical and Translational Science Institute (CTSI), will step down from her positions at Duke on December 31, 2022, to begin a new role as Dean of the Wake Forest University School of Medicine in January 2023.

Post-menopausal women on hormone replacement therapy had a lower risk of developing a painful shoulder condition known as adhesive capsulitis compared to women who did not receive estrogen, according to a study led by Duke Health researchers.

The initial gift for the Duke Climate Commitment has provided funding for Climate and Health Data Expeditions, where interdisciplinary teams, pursue research on data-driven topics examining climate impacts and human health.

Duke’s researchers had another banner year of successes, according to the 2021–2022 research annual report . School of Medicine faculty and funding played an important role.